NCT03584061

Brief Summary

This study evaluates the possible beneficial effect of fat grafting for post herpetic neuralgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 12, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

February 9, 2021

Status Verified

February 1, 2021

Enrollment Period

1.1 years

First QC Date

May 1, 2018

Last Update Submit

February 4, 2021

Conditions

Keywords

Chronic PainHerpes ZosterPain

Outcome Measures

Primary Outcomes (1)

  • Neuropathic pain [LEVEL OF PAIN]

    Neuropathic Pain Symptom inventory (NPSI), Questionnaire. NPSI consists of 12 items in total: 10 items investigates differential symptoms descriptors and 2 items evaluate spontaneous and paroxysmal spontaneous pain. The tool evaluates mean pain intensity in the last 24h in a verbal numeric scale from zero (no pain) to 10 (worst imaginable pain). Total pain intensity score may be calculated by the sum of the 10 descriptors. The descriptors are: Burning, Squeezing, Pressure, Electric Shocks, Stabbing, Provoked by brushing. Provoked by pressure, Evoked by cold stimulation, Pins and needles, Tingling.

    6 months

Secondary Outcomes (1)

  • Quality of life [QUALITY OF LIFE/ SATISFACTION]

    6 months

Study Arms (1)

Fat grafting/fat transplant.

EXPERIMENTAL

Each patient receives fat grafting to the site of dermal pain. Fat is to be harvested for either the abdomen or the thigh.

Procedure: Fat grafting

Interventions

Fat graftingPROCEDURE

The area of dermal pain is identified and marked prior to surgery. The surgery starts with liposuction, either on the abdomen or the thigh. The harvested fat is prepared for fat grafting by sedimenting it for 10 minutes. The fat is then injected into the painful area, marked pre-surgery.

Also known as: Fat transplant, lipofilling
Fat grafting/fat transplant.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18
  • Pain in area of former VZV-infection.
  • Pain present over 3 months after reactivation of VZV and is present at least 4 days a week and of intensity \>3 on the VAS-scale.

You may not qualify if:

  • Psychiatric illness that could potentially affect the study.
  • Other indication for fat grafting than pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Odense University Hospital

Odense, Funen, 5000, Denmark

Location

Related Publications (2)

  • Sollie M, Thomsen JB, Sorensen JA. Autologous fat grafting seems to alleviate postherpetic neuralgia - a feasibility study investigating patient-reported levels of pain. J Plast Reconstr Aesthet Surg. 2021 Feb;74(2):350-356. doi: 10.1016/j.bjps.2020.08.038. Epub 2020 Aug 21.

  • Sollie M, Sorensen JA. Treatment of chronic post-herpetic neuralgia with autologous fat grafts: a first-in-the-world case report. Br J Pain. 2019 Nov;13(4):239-243. doi: 10.1177/2049463718817570. Epub 2018 Nov 28.

MeSH Terms

Conditions

Neuralgia, PostherpeticHerpes ZosterChronic PainPain

Condition Hierarchy (Ancestors)

NeuralgiaPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsVaricella Zoster Virus InfectionHerpesviridae InfectionsDNA Virus InfectionsVirus DiseasesInfections

Study Officials

  • Jens A Sørensen, MD. PhD.

    Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: The five patients included will all receive a fat graft in the area affected by PHN.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, M.D, Dept. of Plastic and Reconstructive Surgery

Study Record Dates

First Submitted

May 1, 2018

First Posted

July 12, 2018

Study Start

May 1, 2018

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

February 9, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations